Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Tissue Distribution of trans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes.

Wang S, Wang Z, Yang S, Yin T, Zhang Y, Qin Y, Weinreb RN, Sun X.

J Ophthalmol. 2017;2017:4052094. doi: 10.1155/2017/4052094. Epub 2017 Mar 20.

2.

Effect of Resveratrol-Based Nutritional Supplement on Choroidal Thickness: A Pilot Study.

Wang S, Moonasar N, Xiao X, Yin T, Weinreb RN, Sun X.

Curr Eye Res. 2016 Oct;41(10):1339-1345. Epub 2016 Feb 10.

PMID:
26863155
3.

The role and modulation of autophagy in experimental models of myocardial ischemia-reperfusion injury.

Chen-Scarabelli C, Agrawal PR, Saravolatz L, Abuniat C, Scarabelli G, Stephanou A, Loomba L, Narula J, Scarabelli TM, Knight R.

J Geriatr Cardiol. 2014 Dec;11(4):338-48. doi: 10.11909/j.issn.1671-5411.2014.01.009. Review.

4.

Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients.

Richer S, Patel S, Sockanathan S, Ulanski LJ 2nd, Miller L, Podella C.

Nutrients. 2014 Oct 17;6(10):4404-20. doi: 10.3390/nu6104404.

5.

Sub-acute toxicity profile of a modified resveratrol supplement.

Sangeetha MK, Vallabi DE, Sali VK, Thanka J, Vasanthi HR.

Food Chem Toxicol. 2013 Sep;59:492-500. doi: 10.1016/j.fct.2013.06.037. Epub 2013 Jun 29.

PMID:
23819915
6.

Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement.

Richer S, Stiles W, Ulanski L, Carroll D, Podella C.

Nutrients. 2013 Jun 4;5(6):1989-2005. doi: 10.3390/nu5061989.

7.

Sirtuin activators and inhibitors.

Villalba JM, Alcaín FJ.

Biofactors. 2012 Sep-Oct;38(5):349-59. doi: 10.1002/biof.1032. Epub 2012 Jun 25. Review.

8.

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.

Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DK.

Nutr Res. 2011 Nov;31(11):842-7. doi: 10.1016/j.nutres.2011.09.028.

PMID:
22118755
9.
10.

Hormetic response of resveratrol against cardioprotection.

Juhasz B, Mukherjee S, Das DK.

Exp Clin Cardiol. 2010 Winter;15(4):e134-8.

11.

Restoration of altered microRNA expression in the ischemic heart with resveratrol.

Mukhopadhyay P, Mukherjee S, Ahsan K, Bagchi A, Pacher P, Das DK.

PLoS One. 2010 Dec 23;5(12):e15705. doi: 10.1371/journal.pone.0015705.

12.

Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action.

Mukherjee S, Ray D, Lekli I, Bak I, Tosaki A, Das DK.

Can J Physiol Pharmacol. 2010 Nov;88(11):1017-25. doi: 10.1139/y10-082.

13.

Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]

Juhasz B, Das DK, Kertesz A, Juhasz A, Gesztelyi R, Varga B.

Mol Cell Biochem. 2011 Feb;348(1-2):199-203. doi: 10.1007/s11010-010-0615-2. Epub 2010 Nov 4. Erratum in: Mol Cell Biochem. 2011 Feb;348(1-2):205. Juhaz, Bela [corrected to Juhasz, Bela].

PMID:
21052791

Supplemental Content

Loading ...
Support Center